Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma

Japanese Journal of Cancer Research

Volumn 92, Issue 2, 2001, Pages 211-219

  Haga, Sei ^a   Hinoshita, Eiji ^a   Ikezaki, Kiyonobu ^a   Fukui, Masashi ^a   Scheffer, George L ^b   Uchiumi, Takeshi ^a   Kuwano, Michihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ABC transporter; Anticancer agents; Glioblastoma; MRP subfamily

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; CISPLATIN; COMPLEMENTARY DNA; DOXORUBICIN; ETOPOSIDE; LIPOFECTAMINE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; NITROSOUREA; VINCRISTINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE FUNCTION; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035080458     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01084.x     Document Type: Article

References (32)

1. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
2. Biochemistry of multidrug resistance mediated by the multidrug transporter
3. The biochemistry of P-glyco-protein-mediated multidrug resistance
4. Biology of the multidrug resistance-associated protein, MRP
5. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
6. The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man
7. A human canalicular multi-specific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
8. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome
9. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome
10. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)
11. Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport
12. Transfected rat cMOAT is functionally expressed on the apical membrane in Madin-Darby canine kidney (MDCK) cells
13. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
14. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells
15. MRP3, an organic anion transporter able to transport anti-cancer drugs
16. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3)
17. cDNA cloning of a short type of multidrug resistance protein homologue, SMRP, from a human lung cancer cell line
18. Chemotherapy of nonirradiated malignant gliomas. Phase II: Study of the combination of methyl-CCNU, vincristine, and procarbazine
19. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma
20. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
21. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
22. Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens
23. Expression of multidrug resistance protein gene in patients with glioma after chemotherapy
24. Chemosensitization of spontaneous multidrug resistance by a 1,4 dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1
25. A novel method for real time quantitative RT-PCR
26. Increased expression of an ABC superfamily transporter, multidrug resistance protein 2 (MRP2) in human colorectal carcinomas
27. Location of a protease hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1
28. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells
29. Effect of multidrug resistance reversing agents on the transporting activity of human canalicular multispecific organic anion transporter (cMOAT)
30. Enhanced transport of anti-cancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)
31. Drug resistance and ATP dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells
32. Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response